Strata Skin Sciences Inc (SSKN)
0.3831
+0.01
(+3.54%)
USD |
NASDAQ |
May 31, 16:00
0.387
0.00 (0.00%)
After-Hours: 20:00
Strata Skin Sciences Enterprise Value: 23.27M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 23.27M |
| May 30, 2024 | 22.81M |
| May 29, 2024 | 23.16M |
| May 28, 2024 | 23.58M |
| May 24, 2024 | 23.34M |
| May 23, 2024 | 22.81M |
| May 22, 2024 | 23.20M |
| May 21, 2024 | 23.51M |
| May 20, 2024 | 23.36M |
| May 17, 2024 | 23.64M |
| May 16, 2024 | 23.22M |
| May 15, 2024 | 24.56M |
| May 14, 2024 | 23.26M |
| May 13, 2024 | 23.31M |
| May 10, 2024 | 22.99M |
| May 09, 2024 | 23.20M |
| May 08, 2024 | 23.52M |
| May 07, 2024 | 24.23M |
| May 06, 2024 | 24.49M |
| May 03, 2024 | 24.46M |
| May 02, 2024 | 23.86M |
| May 01, 2024 | 24.22M |
| April 30, 2024 | 24.21M |
| April 29, 2024 | 24.92M |
| April 26, 2024 | 27.88M |
| Date | Value |
|---|---|
| April 25, 2024 | 28.39M |
| April 24, 2024 | 29.47M |
| April 23, 2024 | 28.77M |
| April 22, 2024 | 28.42M |
| April 19, 2024 | 28.95M |
| April 18, 2024 | 28.51M |
| April 17, 2024 | 28.16M |
| April 16, 2024 | 27.28M |
| April 15, 2024 | 26.14M |
| April 12, 2024 | 27.72M |
| April 11, 2024 | 28.30M |
| April 10, 2024 | 28.07M |
| April 09, 2024 | 26.49M |
| April 08, 2024 | 27.02M |
| April 05, 2024 | 27.33M |
| April 04, 2024 | 27.30M |
| April 03, 2024 | 25.26M |
| April 02, 2024 | 25.84M |
| April 01, 2024 | 23.86M |
| March 31, 2024 | 23.09M |
| March 28, 2024 | 21.51M |
| March 27, 2024 | 23.86M |
| March 26, 2024 | 24.39M |
| March 25, 2024 | 25.44M |
| March 22, 2024 | 25.72M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
18.47M
Minimum
Nov 13 2023
87.60M
Maximum
Aug 02 2019
43.97M
Average
42.35M
Median
Dec 03 2021
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 680.29M |
| Retractable Technologies Inc | -13.51M |
| Xtant Medical Holdings Inc | 116.30M |
| Asensus Surgical Inc | 52.33M |
| Catheter Precision Inc | 2.370M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.368M |
| Revenue (Quarterly) | 6.754M |
| Total Expenses (Quarterly) | 9.643M |
| EPS Diluted (Quarterly) | -0.10 |
| Gross Profit Margin (Quarterly) | 45.60% |
| Profit Margin (Quarterly) | -49.87% |
| Earnings Yield | -86.14% |
| Normalized Earnings Yield | -62.31 |